Keizo Fukushima

1.0k total citations
52 papers, 862 citations indexed

About

Keizo Fukushima is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Pharmaceutical Science. According to data from OpenAlex, Keizo Fukushima has authored 52 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pediatrics, Perinatology and Child Health, 11 papers in Infectious Diseases and 10 papers in Pharmaceutical Science. Recurrent topics in Keizo Fukushima's work include Pharmacological Effects and Toxicity Studies (13 papers), Renal Transplantation Outcomes and Treatments (8 papers) and HIV/AIDS drug development and treatment (8 papers). Keizo Fukushima is often cited by papers focused on Pharmacological Effects and Toxicity Studies (13 papers), Renal Transplantation Outcomes and Treatments (8 papers) and HIV/AIDS drug development and treatment (8 papers). Keizo Fukushima collaborates with scholars based in Japan, United States and Netherlands. Keizo Fukushima's co-authors include Kanji Takada, Nobuyuki Sugioka, Yukako Ιtο, Ryo Hasegawa, Nobuhito Shibata, Asako Nishimura, Hiromi Morita, Kenta Haraya, Shinji Kobuchi and Akira Okada and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Keizo Fukushima

50 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keizo Fukushima Japan 15 410 184 161 140 129 52 862
Nobuyuki Sugioka Japan 23 915 2.2× 404 2.2× 340 2.1× 284 2.0× 264 2.0× 87 1.8k
Aly A. Abdelbary Egypt 20 1.1k 2.8× 231 1.3× 342 2.1× 94 0.7× 125 1.0× 28 1.6k
Patrice Muret France 17 159 0.4× 269 1.5× 120 0.7× 56 0.4× 68 0.5× 72 999
André Huss Eriksson Denmark 12 164 0.4× 100 0.5× 99 0.6× 96 0.7× 68 0.5× 17 487
Maha M. Amin Egypt 20 483 1.2× 51 0.3× 248 1.5× 79 0.6× 53 0.4× 47 1.1k
Vikas Bali India 14 571 1.4× 90 0.5× 155 1.0× 44 0.3× 49 0.4× 18 856
Imran Shair Mohammad China 19 222 0.5× 48 0.3× 451 2.8× 173 1.2× 36 0.3× 36 1.1k
Nida Akhtar India 14 261 0.6× 117 0.6× 128 0.8× 66 0.5× 23 0.2× 42 679
Wessam H. Abd-Elsalam Egypt 16 541 1.3× 96 0.5× 176 1.1× 36 0.3× 34 0.3× 27 973
Sally A. El‐Zahaby Egypt 15 280 0.7× 61 0.3× 176 1.1× 56 0.4× 30 0.2× 34 687

Countries citing papers authored by Keizo Fukushima

Since Specialization
Citations

This map shows the geographic impact of Keizo Fukushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Fukushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Fukushima more than expected).

Fields of papers citing papers by Keizo Fukushima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keizo Fukushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Fukushima. The network helps show where Keizo Fukushima may publish in the future.

Co-authorship network of co-authors of Keizo Fukushima

This figure shows the co-authorship network connecting the top 25 collaborators of Keizo Fukushima. A scholar is included among the top collaborators of Keizo Fukushima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keizo Fukushima. Keizo Fukushima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotta, T, Keizo Fukushima, Kei Irie, et al.. (2024). Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics. Current Therapeutic Research. 102. 100775–100775.
2.
Fukushima, Keizo, et al.. (2024). External validation and updating of the infusion rate individualization of soybean oil–based intravenous lipid emulsion: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 48(5). 580–587. 1 indexed citations
3.
Fukushima, Keizo, Tomoyuki Mizuno, Hajime Ichikawa, et al.. (2023). Model‐Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease. Clinical Pharmacology & Therapeutics. 115(2). 239–247. 1 indexed citations
4.
Colman, Ruben J., Tomoyuki Mizuno, Keizo Fukushima, et al.. (2022). Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology & Therapeutics. 57(5). 524–539. 12 indexed citations
5.
Fukushima, Keizo, Kenji Omura, Akira Okada, et al.. (2021). Individualization of the infusion rate of a soybean oil–based intravenous lipid emulsion for inpatients, based on baseline triglyceride concentrations: A population pharmacokinetic approach. Journal of Parenteral and Enteral Nutrition. 46(1). 104–113. 2 indexed citations
6.
Fujimoto, Ayumi, Keizo Fukushima, Kei Irie, et al.. (2020). Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts. Journal of Clinical Pharmacy and Therapeutics. 46(1). 190–197. 3 indexed citations
7.
Irie, Kei, Akira Okada, Yoshio Masuda, et al.. (2018). Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy. Journal of Oncology Pharmacy Practice. 25(4). 865–868. 1 indexed citations
8.
Shimizu, Yuki, et al.. (2014). Preparation and pharmaceutical evaluation of nano-fiber matrix supported drug delivery system using the solvent-based electrospinning method. International Journal of Pharmaceutics. 464(1-2). 243–251. 42 indexed citations
9.
Fukushima, Keizo, et al.. (2013). Dose Adjustment Strategy of Cyclosporine A in Renal Transplant Patients: Evaluation of Anthropometric Parameters for Dose Adjustment and C0 vs. C2 Monitoring in Japan, 2001-2010. International Journal of Medical Sciences. 10(12). 1665–1673. 7 indexed citations
10.
Kobuchi, Shinji, et al.. (2013). Effects of oxidative stress on the pharmacokinetics and hepatic metabolism of atazanavir in rats. Free Radical Research. 47(4). 291–300. 7 indexed citations
11.
Kobuchi, Shinji, Keizo Fukushima, Hiroaki Aoyama, et al.. (2013). Effects of Obesity Induced by High-Fat Diet on the Pharmacokinetics of Atazanavir in Rats. Drug Metabolism Letters. 7(1). 39–46. 4 indexed citations
12.
Fukushima, Keizo, et al.. (2013). Time-Dependent Interaction of Ritonavir in Chronic Use: The Power Balance Between Inhibition and Induction of P-Glycoprotein and Cytochrome P450 3A. Journal of Pharmaceutical Sciences. 102(6). 2044–2055. 13 indexed citations
13.
Fukushima, Keizo, Shinji Kobuchi, Masakazu SHIBATA, Kanji Takada, & Nobuyuki Sugioka. (2011). Decrease in Brain Distribution of Fluvoxamine in Experimental Hyperlipidemic Rats. Journal of Pharmacy & Pharmaceutical Sciences. 14(3). 414–414. 3 indexed citations
14.
Ιtο, Yukako, et al.. (2011). Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats. Drug Development and Industrial Pharmacy. 37(12). 1387–1393. 43 indexed citations
15.
Ιtο, Yukako, et al.. (2011). Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles. International Journal of Pharmaceutics. 407(1-2). 126–131. 48 indexed citations
16.
Fukushima, Keizo, et al.. (2010). Pharmacokinetic and Pharmacodynamic Evaluation of Insulin Dissolving Microneedles in Dogs. Diabetes Technology & Therapeutics. 12(6). 465–474. 36 indexed citations
17.
Konishi, Hiroki, Keizo Fukushima, Masaki Sumi, et al.. (2009). Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia. Fundamental and Clinical Pharmacology. 24(4). 457–462. 3 indexed citations
18.
Sugioka, Nobuyuki, Kenta Haraya, Keizo Fukushima, Yukako Ιtο, & Kanji Takada. (2009). Effects of obesity induced by high‐fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. Biopharmaceutics & Drug Disposition. 30(9). 532–541. 14 indexed citations
19.
Sugioka, Nobuyuki, Katsukuni Fujimoto, Yuka Tanaka, et al.. (2009). Comparison of Pharmacokinetics of Cyclosporine A in Cadaveric and Living- Related Renal Transplant Recipients and in an Experimental Rat Model of Renal Failure. Drug Metabolism Letters. 3(3). 152–161. 2 indexed citations
20.
Fukushima, Keizo, et al.. (2008). Long-Term Pharmacokinetic Efficacy and Safety of Low-Dose Ritonavir as a Booster and Atazanavir Pharmaceutical Formulation Based on Solid Dispersion System in Rats. Biological and Pharmaceutical Bulletin. 31(6). 1209–1214. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026